Loading company…
Zhejiang Maida Peisi develops neuromodulation products for digestive system conditions.
Founded in 2018, Zhejiang Maida Peisi Medical Technology is based in Hangzhou, China. Its neuromodulation products target inflammatory bowel disease, diabetes mellitus and functional gastrointestinal disorders. In July 2022, the company raised Series A+ funding from Phoenix Tree Capital Partners for clinical work, registration and manufacturing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Zhejiang Maida Peisi Medical Technology? This is my company